INNO-LiPA HLA-B Update Plus 100 - Taiwan Registration 57c8661046185b7f278137cec6c36d0c

Access comprehensive regulatory information for INNO-LiPA HLA-B Update Plus 100 in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 57c8661046185b7f278137cec6c36d0c and manufactured by FUJIREBIO EUROPE N.V.. The authorized representative in Taiwan is Taiwan Fu Pharmaceutical Co., Ltd.

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.